Foxin has impacted the way our business operates, so much so that it now contributes to our strategy going forward as it relates to growth, expansion, and new opportunities for our clients and our employees.
Compresses the peri-wound to remove fluid from the wound bed, shown in vivo to contribute to increased activity in the lymphatic system.24,25
Shown (in vivo) to maintain an efficient blood supply (perfusion),15 helping to support the immune response and remove debris.15 Compressive forces and tissue displacement help form new capillaries from existing blood vessels.24,25
PICO sNPWT helps stimulate cells to proliferate and form more granulation tissue than traditional NPWT.**27 The development of granulation tissue has been shown to help wound contraction in open wounds.1,3,28,29
Significantly reduces established mature biofilm bacteria by more than 97%.***31 Furthermore, once wound exudate is absorbed, in-vitro testing has shown that 99% of bacteria is locked in the dressing.***30
Shown to reduce the build-up of interstitial fluid and minimise compression of blood vessels, improving the functionality of damaged lymph vessels and increasing the efficiency of functional lymph vessels, helping to reduce oedema (animal study).24
Emon has impacted the way our business operates, so much so that it now contributes to our strategy going forward as it relates to growth, expansion, and new opportunities for our clients and our employees.
Mion has impacted the way our business operates, so much so that it now contributes to our strategy going forward as it relates to growth, expansion, and new opportunities for our clients and our employees.
Tico has impacted the way our business operates, so much so that it now contributes to our strategy going forward as it relates to growth, expansion, and new opportunities for our clients and our employees.